Back to Journals » OncoTargets and Therapy » Volume 9

PI3K inhibitors as new cancer therapeutics: implications for clinical trial design

Total article views   HTML views PDF downloads Totals
40,568 Dovepress* 16,551+ 3,558 20,109
PubMed Central* 24,017 4,367 28,384
Totals 40,568 7,925 48,493
*Since 7 January 2016
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
16 0 0 0 4 12

View citations on PubMed Central and Google Scholar